DDX11 and osteosarcoma: The prediction about a putative tumorigenic role of DDX11 appears to be confirmed by contemporary reports indicating that DDX11 over-expression promotes hepatocellular carcinoma and osteosarcoma growth and metastasis, while DDX11 downregulation restrains tumoral development and progression in xenograft mouse models of these cancers, as we have summarized herein.